As one of 30 exhibitors, in vitro diagnostics (IVD) manufacturer numares HEALTH presented its products and developments in the fields of cardiology, oncology and nephrology to an interested professional audience in the cafeteria of the Roche company complex.
numares HEALTH develops innovative IVD tests (e.g. for the early detection of diseases) based on patented algorithms and unique know-how in the field of nuclear magnetic resonance spectroscopy. The company has developed a simple blood test allowing for a differentiated analysis of lipoprotein subclasses in a high throughput for the first time. The test results enable a better prediction of the risk of cardiovascular disease.
On a fee-for-service basis, numares HEALTH offers its IVD tests to the pharmaceutical industry which, in the context of clinical trials, investigates the therapeutic effects of drugs for example.
"Our developments in the field of in vitro diagnostics have aroused considerable interest among Roche employees”, says Ralf Tusch, Director of Marketing & Sales at numares HEALTH. "The intimate, exclusive atmosphere was the perfect setting for high quality contacts and discussions. We at numares are thrilled to have had this opportunity to participate in and benefit from the Roche Service Day.”
Media contact
numares AG
Dipl.-Biol. Christiane Proll, MBA
Tel.: +49 941 2809 49-14
E-Mail: christiane.proll(at)numares.com
IRA WÜLFING KOMMUNIKATION GmbH
Dr. Reinhard Saller
Tel.: +49 89 2000 30-38
E-Mail: reinhard.saller(at)wuelfing-kommunikation.de